DBV Technologies (DBVT) Revenue (2020 - 2026)
DBV Technologies (DBVT) reported Revenue of $900000.0 for Q1 2026, up 12.5% year-over-year from $800000.0 in Q1 2025, and up 39.53% quarter-over-quarter from $645000.0 in Q4 2025.
DBV Technologies (DBVT) Revenue (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of Revenue data on file, last reported at $900000.0 in Q1 2026.
- Revenue for Q1 2026 came in at $900000.0, up 12.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.8 million (up 63.21% YoY), and the FY2025 annual result was $5.6 million, up 35.77% from the prior year.
- Revenue rose to $900000.0 in Q1 2026 per DBVT's latest filing, from $645000.0 in the prior quarter.
- Over five years, Revenue peaked at $8.9 million in Q4 2023 and troughed at -$1.3 million in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.5 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue sank 144.47% in 2022, then surged 780.6% in 2023.
- A 5-year view of Revenue shows it stood at -$1.3 million in 2022, then surged by 780.6% to $8.9 million in 2023, then tumbled by 94.24% to $511000.0 in 2024, then gained by 26.22% to $645000.0 in 2025, then soared by 39.53% to $900000.0 in 2026.
- Business Quant data shows DBVT's Revenue at $900000.0 in Q1 2026, $645000.0 in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 900,000.00 |
| Dec 31, 2025 | 645,000.00 |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 511,000.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 2.37 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.19 Mn |
| Dec 31, 2022 | -1.30 Mn |
| Sep 30, 2022 | 2.07 Mn |
| Jun 30, 2022 | 1.53 Mn |
| Mar 31, 2022 | 2.55 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | 1.49 Mn |